ESMA LIBRARY
REFINE YOUR SEARCH
Sections
- (-) Remove Corporate Disclosure filter Corporate Disclosure
- (-) Remove MiFID - Investor Protection filter MiFID - Investor Protection
- Brexit (30) Apply Brexit filter
- Post Trading (28) Apply Post Trading filter
- MiFID - Secondary Markets (27) Apply MiFID - Secondary Markets filter
- Corporate Information (20) Apply Corporate Information filter
- COVID-19 (18) Apply COVID-19 filter
- Press Releases (18) Apply Press Releases filter
- Board of Supervisors (17) Apply Board of Supervisors filter
- Credit Rating Agencies (17) Apply Credit Rating Agencies filter
- Fund Management (16) Apply Fund Management filter
- IFRS Supervisory Convergence (15) Apply IFRS Supervisory Convergence filter
- CESR Archive (13) Apply CESR Archive filter
- Supervisory convergence (13) Apply Supervisory convergence filter
- Joint Committee (11) Apply Joint Committee filter
- Market Integrity (11) Apply Market Integrity filter
- Innovation and Products (9) Apply Innovation and Products filter
- MiFID II: Transparency Calculations and DVC (7) Apply MiFID II: Transparency Calculations and DVC filter
- Trade Repositories (7) Apply Trade Repositories filter
- Benchmarks (6) Apply Benchmarks filter
- Corporate Governance (5) Apply Corporate Governance filter
- Prospectus (5) Apply Prospectus filter
- Securities Financing Transactions (5) Apply Securities Financing Transactions filter
- Short Selling (5) Apply Short Selling filter
- Warnings and publications for investors (5) Apply Warnings and publications for investors filter
- Corporate Finance (4) Apply Corporate Finance filter
- Speeches (4) Apply Speeches filter
- Sustainable finance (4) Apply Sustainable finance filter
- IAS Regulation (3) Apply IAS Regulation filter
- Market Abuse (3) Apply Market Abuse filter
- Guidelines and Technical standards (2) Apply Guidelines and Technical standards filter
- Management Board (2) Apply Management Board filter
- Risk Analysis & Economics - Markets Infrastructure Investors (2) Apply Risk Analysis & Economics - Markets Infrastructure Investors filter
- Securitisation (2) Apply Securitisation filter
- Trading (2) Apply Trading filter
- Transparency (2) Apply Transparency filter
- Audit (1) Apply Audit filter
- CCP Directorate (1) Apply CCP Directorate filter
- Crowdfunding (1) Apply Crowdfunding filter
- International cooperation (1) Apply International cooperation filter
- Securities and Markets Stakeholder Group (1) Apply Securities and Markets Stakeholder Group filter
Type of document
- (-) Remove Statement filter Statement
- (-) Remove Q&A filter Q&A
- Letter (170) Apply Letter filter
- Guidelines & Recommendations (80) Apply Guidelines & Recommendations filter
- Reference (62) Apply Reference filter
- Opinion (61) Apply Opinion filter
- Press Release (57) Apply Press Release filter
- Consultation Paper (38) Apply Consultation Paper filter
- Final Report (35) Apply Final Report filter
- Investor Warning (26) Apply Investor Warning filter
- Report (20) Apply Report filter
- Speech (15) Apply Speech filter
- Compliance table (11) Apply Compliance table filter
- Technical Advice (6) Apply Technical Advice filter
- Technical Standards (4) Apply Technical Standards filter
- CESR Document (3) Apply CESR Document filter
- Decision (3) Apply Decision filter
- Annual Report (2) Apply Annual Report filter
Date | Ref. | Title | Section | Type | Download | Info | Summary | Related Documents | Translated versions |
---|---|---|---|---|---|---|---|---|---|
25/02/2021 | ESMA71-99-1573 | ESMA appoints new chair of its Corporate Reporting Standing Committee | Corporate Disclosure | Statement | PDF 78.55 KB |
||||
23/02/2021 | ESMA22-105-1307 | Introductory statement on GameStop share trading- Steven Maijoor | Market Integrity, MiFID - Investor Protection | Statement | PDF 96.93 KB |
||||
17/02/2021 | ESMA70-155-11809 | Episodes of very high volatility in trading of certain stocks | Market Integrity, MiFID - Investor Protection | Statement | PDF 107.47 KB |
||||
28/01/2021 | ESMA71-99-1544 | ESMA appoints new IPISC and CNS Chairs | Board of Supervisors, Corporate Information, MiFID - Investor Protection, Sustainable finance | Statement | PDF 87.3 KB |
||||
28/01/2021 | ESMA71-99-1544 | ESMA appoints new IPISC and CSN chairs | Board of Supervisors, Corporate Information, MiFID - Investor Protection, Sustainable finance | Statement | |||||
13/01/2021 | ESMA35-43-2509 | Reminder to firms of the MiFID II rules on ‘reverse solicitation’ in the context of the recent end of the UK transition period | Brexit, MiFID - Investor Protection | Statement | PDF 151.2 KB |
||||
22/12/2020 | ESMA35-43-349 | Q&As on MiFID II and MiFIR investor protection topics | MiFID - Investor Protection, Supervisory convergence | Q&A | PDF 651.6 KB |
||||
03/11/2020 | ESMA71-99-1423 | QA Fast Track Peer Review- Wirecard | Corporate Disclosure, Guidelines and Technical standards, Supervisory convergence | Q&A | PDF 248.14 KB |
||||
28/10/2020 | ESMA32-63-1041 | Public Statement on the European Common Enforcement Priorities 2020 | Corporate Disclosure, IFRS Supervisory Convergence | Statement | PDF 266.78 KB |
||||
15/07/2020 | ESMA71-99-1364 | ESMA Statement on Assessment of German Financial Reporting Regime | Corporate Disclosure, Guidelines and Technical standards, Press Releases, Supervisory convergence | Statement | PDF 88.5 KB |
||||
11/06/2020 | ESMA32-334-245 | ESMA response to EC Consultation on NFRD | Corporate Disclosure, Sustainable finance | Statement | PDF 429.86 KB |
||||
20/05/2020 | ESMA32-63-972 | Implications of the COVID-19 outbreak on the half-yearly financial reports | Corporate Disclosure, COVID-19 | Statement | PDF 111.97 KB |
||||
06/05/2020 | ESMA35-43-2391 | Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity | COVID-19, MiFID - Investor Protection | Statement | PDF 118.75 KB |
||||
17/04/2020 | ESMA32-51-370 | Q&A on ESMA Guidelines on Alternative Performance Measures | Corporate Disclosure, Corporate Information | Q&A | PDF 329.01 KB |
||||
31/03/2020 | ESMA35-36-1919 | Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 | COVID-19, MiFID - Investor Protection | Statement | PDF 89.84 KB |
||||
25/03/2020 | ESMA32-63-951 | Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 | Corporate Disclosure, COVID-19 | Statement | PDF 135.91 KB |
||||
20/03/2020 | ESMA35-43-2348 | ESMA Statement on COVID-19 telephone recording | COVID-19, MiFID - Investor Protection | Statement | PDF 114.12 KB |
||||
27/02/2020 | ESMA/2014/677-REV | Information on shareholder cooperation and acting in concert under the Takeover Bids Directive | Corporate Disclosure, Corporate Governance | Statement | PDF 368.97 KB |
The European Securities and Markets Authority (ESMA) has published an update to its statement on practices governed by the Takeover Bid Directive (TBD), focused on shareholder cooperation issues relating to acting in concert and the appointment of board members. The update concerns a change to the Croatian creep-in threshold and secondary threshold in Appendix B. The statement contains a White List of activities that shareholders can cooperate on without the presumption of acting in concert. It also contains information on how shareholders may cooperate in order to secure board member appointments by setting out factors that national authorities may take into account when considering whether shareholders are acting in concert.The statement is in response to a request by the European Commission for clarity on these issues, following its 2012 report on the application of the TBD. It is based on information collected about the TBD’s application and common practices across the European Economic Area (EEA). The statement was prepared by the Takeover Bids Network, a permanent working group, under ESMA’s auspices, that promotes the exchange of information on practices and application of the TBD across EEA. |
|||
22/10/2019 | ESMA32-63-791 | European common enforcement priorities for 2019 annual financial reports | Corporate Disclosure, IAS Regulation | Statement | PDF 482.56 KB |
||||
12/07/2019 | ESMA35-36-1743 | Statement Product Intervention | MiFID - Investor Protection | Statement | PDF 104.99 KB |